Olympus Corporation (OLYMY)
OTCMKTS
· Delayed Price · Currency is USD
12.55
+0.04 (0.32%)
Apr 21, 2025, 9:30 AM EDT
Olympus Revenue
Olympus had revenue of 251.19B JPY in the quarter ending December 31, 2024, with 5.07% growth. This brings the company's revenue in the last twelve months to 993.33B, up 8.43% year-over-year. In the fiscal year ending March 31, 2024, Olympus had annual revenue of 936.21B with 6.16% growth.
Revenue (ttm)
993.33B JPY
Revenue Growth
+8.43%
P/S Ratio
2.25
Revenue / Employee
34.45M JPY
Employees
28,838
Market Cap
14.21B USD
Revenue Chart
* This company reports financials in JPY.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 936.21B | 54.29B | 6.16% |
Mar 31, 2023 | 881.92B | 13.06B | 1.50% |
Mar 31, 2022 | 868.87B | 138.32B | 18.93% |
Mar 31, 2021 | 730.54B | -66.87B | -8.39% |
Mar 31, 2020 | 797.41B | 3.55B | 0.45% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
SS Innovations International | 20.65M |
Endo Inc. | 1.76B |
Veradigm | 588.02M |
Northwest Biotherapeutics | 1.38M |
Elite Pharmaceuticals | 70.00M |
Glass House Brands | 200.90M |
BioStem Technologies | 301.83M |
American Oncology Network | 1.76B |